Crossmark

ASO Author Reflections: Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy?

Crossref DOI link: https://doi.org/10.1245/s10434-025-18373-8

Published Online: 2025-09-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Farooq, Mohammad Saad https://orcid.org/0009-0009-8493-6976
Karakousis, Giorgos C.
License Information

Text and Data Mining valid from 2025-09-17

Version of Record valid from 2025-09-17
More Information

Article History

Received: 29 August 2025

Accepted: 31 August 2025

First Online: 17 September 2025

Disclosure

: Giorgos Karakousis received research institutional funds from Merck. Mohammad Saad Farooq has no conflicts of interest to declare that may be relevant to the contents of this study.

Document is current

Any future updates will be listed below